Anuh Pharma Ltd.

View in App
243.50 +2.55 ▲1.1%

19 April 2024, 04:01:00 PM
Volume: 55,007

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.anuhpharma.com
Market Cap 1,220.23 Cr.
Enterprise Value(EV) 1,200.37 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 10.84 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 22.46 Trailing Twelve Months Ending 2023-12
Industry PE 41.01 Trailing Twelve Months Ending 2023-12
Book Value / Share 55.05 Trailing Twelve Months Ending 2023-12
Price to Book Value 4.42 Calculated using Price: 243.50
Dividend Yield 0.82 Period Ending 2023-03
No. of Shares Subscribed 5.01 Cr. 50,112,000 Shares
FaceValue 5
About Anuh Pharma Ltd.
Anuh Pharma incorporated in 1960, is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The company is part of the SK Group, which has evolved as a leading importer, exporter, distributor and manufacturer of bulk drugs, chemicals and pharmaceutical formulations.

Anuh Pharma Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Anuh Pharma Ltd. Performance

View details >>
1 Day
+1.06%
1 Week
+4.30%
1 Month
+9.41%
3 Month
+48.29%
6 Month
+86.23%
1 Year
+171.37%
2 Year
+133.01%
5 Year
+270.51%
10 Year
+823.05%

Anuh Pharma Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 23.55 23.44 15.43 11.38 14.87 8.75 16.12 15.11 15.9
Return on Capital Employed (%) 35.13 34.91 21.61 16.31 20.56 10.87 19.75 19.33 21.05
Return on Assets (%) 13.29 14.37 10.58 8.35 10.44 5.06 8.63 8.99 9.63

Anuh Pharma Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 101 119 141 150 165 162 191 214 241 257
Non Curr. Liab. 0 0 0 0 0 1 3 3 2 9
Curr. Liab. 67 72 47 59 75 163 139 131 161 133
Minority Int.
Equity & Liab. 168 191 187 208 239 326 333 347 404 399
Non Curr. Assets 24 40 50 54 87 103 95 88 97 107
Curr. Assets 144 151 138 154 152 223 238 259 308 292
Misc. Exp. not W/O
Total Assets 168 191 187 208 239 326 333 347 404 399

Anuh Pharma Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 284 326 206 238 321 307 432 487 527 640
Other Income 5 4 8 7 5 4 11 5 6 10
Total Income 289 330 214 245 325 311 443 492 534 651
Total Expenditure -253 -289 -183 -220 -291 -284 -387 -439 -476 -570
PBIDT 36 41 30 26 35 27 56 53 58 80
Interest -1 -1 -1 0 -1 -1 -2 -2 -1 0
Depreciation -3 -2 -2 -2 -2 -7 -15 -12 -10 -9
Taxation -10 -12 -8 -7 -9 -5 -10 -9 -11 -17
Exceptional Items
PAT 22 26 20 17 23 14 28 31 36 54
Adjusted EPS 4 5 4 3 5 3 6 6 7 11

Anuh Pharma Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 15 19 17 26 2 7 49 -19 29 54
Cash Fr. Inv. -5 -12 -5 -20 2 3 -77 52 -8 -43
Cash Fr. Finan. -8 -8 -9 -4 -5 -7 22 -33 -19 -12
Net Change 2 -1 2 2 -1 3 -5 0 2 -2
Cash & Cash Eqvt 2 1 3 5 4 7 2 2 4 2

Anuh Pharma Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 70.45 70.44 70.59 70.59 70.59 70.59 70.59 70.59 69.94
Public 29.55 29.56 29.41 29.41 29.41 29.41 29.41 29.41 30.06
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Anuh Pharma Ltd. Announcements

View details >>
Thu, 18 Apr 2024
Under Regulation 40(10) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Certificate dated 17th March 2024 by Sanjay Doshi and Associates Practicing Company Secretaries for the year ended 31st March 2024 under Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Mon, 08 Apr 2024
Shareholder Meeting / Postal Ballot-Outcome of AGM
We have enclosed pursuant to the BSE email dated 06th April 2024 the covering letter for clarification along with the Revised outcome of 63rd Annual General Meeting of the shareholders meeting dated 18th August 2024.
Mon, 08 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Compliance Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 31st March 2024 received from Bigshare Services Private Limited Registrar and Share Transfer Agent (RTA) of our Company. We request you to kindly take the same on record

Anuh Pharma Ltd. Technical Scans

View details >>
Thu, 18 Apr 2024
Close Within 52 Week High Zone Close Within 52 Week High Zone
Making Higher Highs for 2 Days Making Higher Highs for 2 Days
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months

Anuh Pharma Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 364,015.10 1,525.00 +0.5%
Cipla Ltd. 108,808.58 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. 99,408.67 5,942.65 -0.3%
Divi's Laboratories Ltd. 98,683.96 3,673.85 -1.2%
Mankind Pharma Ltd. 96,037.07 2,362.00 -1.5%
Zydus Lifesciences Ltd. 94,213.69 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. 87,250.69 6,152.25 +1.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.87 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-12 29.34 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.01 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-12 71.36 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-12 55.61 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.68 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 110.54 6,152.25 +1.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.83 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-12 4.20 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.70 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-12 7.57 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-12 10.81 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.00 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 12.92 6,152.25 +1.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-03 0.02 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,152.25 +1.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-03 12.85 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,152.25 +1.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-03 12.85 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,152.25 +1.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,152.25 +1.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,152.25 +1.4%

Anuh Pharma Ltd. FAQ's

What is Anuh Pharma share price?
Can I buy Anuh Pharma shares now?
What is the Dividend Yield of Anuh Pharma?
What is the Market Cap of Anuh Pharma?
What are the key metrics to analyse Anuh Pharma?
What is the 52 Week High and Low of Anuh Pharma?
What is the trend of Anuh Pharma share price?